Surviving COVID-19: Biopsychosocial Impacts, Death Anxiety, and Coping Strategies

Author:

Muazzam Amina1,Naseem Faiqa1,Shakil Muneeba2ORCID,Visvizi Anna34ORCID,Klemens Jolanta5

Affiliation:

1. Department of Psychology, Lahore College for Women University, Jail Road, Lahore 54000, Pakistan

2. Department of Humanities, COMSATS University Islamabad, Lahore Campus, 1.5 KM Defence Road, Off Raiwind Road, Lahore 54000, Pakistan

3. Institute of International Studies (ISM), SGH Warsaw School of Economics, Al. Niepodległości 162, 02-554 Warsaw, Poland

4. Effat College of Business, Effat University, Jeddah 21551, Saudi Arabia

5. PSYCHOMedical, ul. W. Broniewskiego 39, 43-300 Bielsko-Biała, Poland

Abstract

As the COVID-19 pandemic erupted, attempts to contain the spread of the virus took two concurrent forms, including mobility restrictions (aka lockdowns) and the race to produce a vaccine. However, it is quite striking that, amidst both the lockdown and the race to produce a vaccine, the question of how COVID-19 survivors/patients coped with the disease has not received the degree of attention it deserved. To navigate this issue, we employed a sample consisting of 100 COVID-19 survivors; this paper explores the relationship between the biopsychosocial (BPS) impacts of COVID-19, death anxiety, and coping strategies. In this context, the mediating role of death anxiety is placed in the spotlight. The analysis reveals a significant positive association between the BPS impact of COVID-19 and death anxiety and a significant negative association between death anxiety and coping strategies among COVID-19 survivors. Thus, death anxiety mediates the relationship between the BPS impact and the coping strategies that COVID-19 survivors adopt. Given the general recognition of the validity of the BPS model in contemporary medical science and practice, a thorough examination of COVID-19 survivors and their experiences related to surviving is necessary to match the challenges of today, including the increased probability of pandemics.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference66 articles.

1. Developing a sustainable exit strategy for COVID-19: Health, economic and public policy implications;Anderson;J. R. Soc. Med.,2020

2. Democracy in flux: A systemic view on the impact of COVID-19;Parry;Transform. Gov. People Process Policy,2021

3. COVID-19 and privacy: A European dilemma;Renda;Digit. Policy Regul. Gov.,2022

4. Visvizi, A., Troisi, O., and Grimaldi, M. (2023). RIIFORUM 2022: Research and Innovation Forum 2022, Springer. Springer Proceedings in Complexity.

5. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation;Wang;AAPS Pharmscitech,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3